India to United States: Celecoxib Export Trade Route
India has recorded 836 verified shipments of Celecoxib exported to United States, representing a combined trade value of $58.4M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $69.9K USD. The leading Indian exporter is UMEDICA LABORATORIES PRIVATE LIMITED, which accounts for 41% of total export value with 45 shipments worth $23.7M USD. On the buying side, LIFESCIENCE LOGISTICS is the largest importer in United States with $23.6M USD in purchases. The top 3 suppliers β UMEDICA LABORATORIES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED β together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Celecoxib corridor is one of India's established pharmaceutical export routes, with 836 shipments documented worth a combined $58.4M USD. The route is dominated by UMEDICA LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's celecoxib manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $69.9K USD β a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with celecoxib's non-urgent bulk-order profile.
Shipment activity peaks during AprilβJune, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.8%, placing it at rank #14 among India's top celecoxib export destinations globally.
On the import side, key buyers of Indian celecoxib in United States include LIFESCIENCE LOGISTICS, MACLEODS PHARMA USA ,INC, J. KNIPPER & COMPANY and 41 others. LIFESCIENCE LOGISTICS is the single largest importer with 40 shipments valued at $23.6M USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#14
- Annual growth+14.8%
- Demand growth+12.9%
- Regulatory ease82/100
Top 10 Indian Celecoxib Exporters to United States
Showing top 10 of 17 Indian suppliers exporting Celecoxib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UMEDICA LABORATORIES PRIVATE LIMITED Avg $527.1K per shipment | 45 | $23.7M | 40.6% |
| 2 | MACLEODS PHARMACEUTICALS LTD Avg $278.6K per shipment | 51 | $14.2M | 24.3% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED Avg $27.3K per shipment | 316 | $8.6M | 14.8% |
| 4 | CIPLA LIMITED Avg $27.9K per shipment | 268 | $7.5M | 12.8% |
| 5 | CADILA PHARMACEUTICALS LIMITED Avg $18.4K per shipment | 47 | $866.3K | 1.5% |
| 6 | WATSON PHARMA PRIVATE LIMITED Avg $48.9K per shipment | 15 | $733.9K | 1.3% |
| 7 | MICRO LABS LIMITED Avg $31.6K per shipment | 20 | $632.3K | 1.1% |
| 8 | LUPIN LIMITED Avg $48.9K per shipment | 11 | $537.5K | 0.9% |
| 9 | TORRENT PHARMACEUTICALS LIMITED Avg $22.4K per shipment | 23 | $515.2K | 0.9% |
| 10 | AUROBINDO PHARMA LIMITED Avg $38.2K per shipment | 9 | $343.9K | 0.6% |
This table shows the top 10 of 17 Indian companies exporting celecoxib to United States, ranked by total trade value. The listed exporters are: UMEDICA LABORATORIES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, CIPLA LIMITED, CADILA PHARMACEUTICALS LIMITED, WATSON PHARMA PRIVATE LIMITED, MICRO LABS LIMITED, LUPIN LIMITED, TORRENT PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED. UMEDICA LABORATORIES PRIVATE LIMITED is the dominant supplier with 45 shipments worth $23.7M USD, giving it a 41% market share. The top 3 suppliers together account for 80% of the total trade value on this route.
Showing top 10 of 17 total Indian exporters on the India to United States Celecoxib export route.
Top 10 Celecoxib Importers in United States
Showing top 10 of 44 known buyers in United States receiving Celecoxib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian celecoxib in United States include LIFESCIENCE LOGISTICS, MACLEODS PHARMA USA ,INC, J. KNIPPER & COMPANY, CIPLA USA INC UPS SUPPLY CHAIN SOLU, J KNIPPER COMPANY, among 44 total buyers. The largest importer is LIFESCIENCE LOGISTICS, accounting for $23.6M USD across 40 shipments β representing 40% of all celecoxib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIFESCIENCE LOGISTICS | 40 | $23.6M | 40.4% |
| 2 | MACLEODS PHARMA USA ,INC | 7 | $13.7M | 23.4% |
| 3 | J. KNIPPER & COMPANY | 147 | $3.7M | 6.4% |
| 4 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 120 | $3.4M | 5.8% |
| 5 | J KNIPPER COMPANY | 85 | $2.6M | 4.4% |
| 6 | NORTHSTAR DISTRIBUTION CENTER 8912 | 71 | $1.4M | 2.3% |
| 7 | J.KNIPPER & COMPANY | 44 | $1.3M | 2.2% |
| 8 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 30 | $1.2M | 2.0% |
| 9 | J. KNIPPER & COMPANY, | 28 | $1.0M | 1.7% |
| 10 | EVERSANA LIFE SCIENCE SERVICES, LLC | 44 | $778.3K | 1.3% |
Showing top 10 of 44 Celecoxib importers in United States on this route.
Top 10 Celecoxib Formulations Imported by United States
Showing top 10 of 454 product formulations shipped on the India to United States Celecoxib route, ranked by trade value
United States imports a wide range of celecoxib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation β CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES] β accounts for $22.6M USD across 2 shipments. There are 454 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CELECOXIB CAPSULES 100MG [PACK OF 500 CAPSULES] | 2 | $22.6M | 38.7% |
| 2 | CELECOXIB CAPSULES 100 MG BNO:BCB92316AMD.10/23 ED. 09/26 PS: 1X500S | 1 | $6.0M | 10.2% |
| 3 | CELECOXIB CAPSULES 100 MG BNO:BCB92315A/BCB92317A MD.10/23 ED.09/28 PS: 1X100S | 2 | $5.2M | 8.8% |
| 4 | CELECOXIB CAPSULES 200 MG BNO:BCC12307C/BCC12307D MFG.DT. OCT-2023 EXP.DT. SEP-2028 PS: 1X100S | 1 | $2.5M | 4.2% |
| 5 | CELECOXIB CAPSULE 200 MG_100S_AP_US | 31 | $1.3M | 2.2% |
| 6 | CELECOXIB CAPSULE 200 MG 100S AP US | 13 | $864.9K | 1.5% |
| 7 | CELECOXIB CAPSULE 100 MG_100S_AP_US | 20 | $563.3K | 1.0% |
| 8 | CELECOXIB CAPSULE 200 MG_500S_AP_US | 13 | $489.5K | 0.8% |
| 9 | CELECOXIB CAPSULE 100 MG 100S AP US | 18 | $440.6K | 0.8% |
| 10 | CELECOXIB CAP 200MG 100S R-01 US. | 3 | $388.2K | 0.7% |
Showing top 10 of 454 Celecoxib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 140 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's celecoxib exports to United States are driven primarily by a handful of large-scale manufacturers. UMEDICA LABORATORIES PRIVATE LIMITED with 45 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market β buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers β UMEDICA LABORATORIES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED β together account for 80% of total trade value on this route. The average shipment value of $69.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as celecoxib capsules 100 mg bno:bcb92316amd.10/23 ed. 09/26 ps: 1x500s and celecoxib capsules 100 mg bno:bcb92315a/bcb92317a md.10/23 ed.09/28 ps: 1x100s, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LIFESCIENCE LOGISTICS is the largest importer with 40 shipments worth $23.6M USD β representing 40% of all celecoxib imports from India on this route. A total of 44 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $58.4M
- Avg. Shipment
- $69.9K
- Suppliers
- 17
- Buyers
- 44
- Transit (Sea)
- ~29 days
- Annual Growth
- +14.8%
Related Analysis
Reverse Direction
United States β India β Celecoxib (Import)Other Celecoxib Routes
Unlock the Full India to United States Celecoxib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 836 shipments on this route.
Frequently Asked Questions β India to United States Celecoxib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Celecoxib to United States?
The leading Indian exporters of Celecoxib to United States are UMEDICA LABORATORIES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED. UMEDICA LABORATORIES PRIVATE LIMITED holds the largest market share at approximately 41% of total trade value on this route.
Q What is the total value of Celecoxib exports from India to United States?
India exports Celecoxib to United States worth approximately $58.4M USD across 836 recorded shipments. The average value per shipment is $69.9K USD.
Q Which ports does India use to ship Celecoxib to United States?
The most active port of origin is MUNDRA SEA with 140 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from India to United States for Celecoxib?
The average transit time for Celecoxib shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during AprilβJune.
Q Is the India to United States Celecoxib trade route growing?
Yes β this trade corridor has seen an annual growth rate of approximately 14.8% with demand growth tracking at 12.9%. The route is ranked #14 among India's top Celecoxib export destinations globally.
Q How many suppliers are active on the India to United States Celecoxib route?
There are currently 17 active Indian suppliers exporting Celecoxib to United States. The market is moderately concentrated with UMEDICA LABORATORIES PRIVATE LIMITED accounting for 41% of total shipment value.
Q Who are the main importers of Celecoxib from India in United States?
The leading importers of Indian Celecoxib in United States include LIFESCIENCE LOGISTICS, MACLEODS PHARMA USA ,INC, J. KNIPPER & COMPANY, CIPLA USA INC UPS SUPPLY CHAIN SOLU, J KNIPPER COMPANY. LIFESCIENCE LOGISTICS is the largest buyer with 40 shipments worth $23.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India β Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce β Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Celecoxib.
- 2.Supplier/Buyer Matching: 17 Indian exporters and 44 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 836 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
836 Verified Shipments
17 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists